{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:13Z","timestamp":1740126433136,"version":"3.37.3"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:p>A 41-year-old woman with monoclonal gammopathy of undetermined significance presented with a 1-year history of livedo racemosa that started on one arm after receiving the Pfizer BioNTech COVID-19 vaccine. Her primary care physician initially thought it was a benign reaction to the COVID-19 vaccine as her symptoms were on the same arm as the site of injection. However, the livedo racemosa subsequently became more widespread after COVID-19 infection.<\/jats:p>","DOI":"10.1093\/ced\/llad138","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T09:51:07Z","timestamp":1681379467000},"page":"945-948","source":"Crossref","is-referenced-by-count":0,"title":["Widespread livedo racemosa"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2281-4921","authenticated-orcid":false,"given":"Patricia","family":"Zhao","sequence":"first","affiliation":[{"name":"University of Virginia School of Medicine , Charlottesville, VA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia A","family":"Luu","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tappy J","family":"Gish","sequence":"additional","affiliation":[{"name":"Pathology, University of Virginia Medical Center , Charlottesville, VA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam S","family":"Raghavan","sequence":"additional","affiliation":[{"name":"Pathology, University of Virginia Medical Center , Charlottesville, VA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A","family":"Gru","sequence":"additional","affiliation":[{"name":"Pathology, University of Virginia Medical Center , Charlottesville, VA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barrett J","family":"Zlotoff","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"2023101015415131000_llad138-B1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5114\/pdia.2013.34165","article-title":"Scleromyxedema: a rare disorder and its treatment difficulties","volume":"30","author":"Koronowska","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"2023101015415131000_llad138-B2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41408-022-00661-1","article-title":"Cutaneous manifestations of monoclonal gammopathy","volume":"12","author":"Claveau","year":"2022","journal-title":"Blood Cancer J"},{"key":"2023101015415131000_llad138-B3","first-page":"1101","article-title":"Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema","volume":"135","author":"Mah\u00e9vas","year":"2020","journal-title":"Blood"},{"key":"2023101015415131000_llad138-B4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/2229-5178.164493","article-title":"Livedo reticularis: a review of the literature","volume":"6","author":"Sajjan","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"2023101015415131000_llad138-B5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaad.2015.12.021","article-title":"Histopathologic characteristics of scleromyxedema: a study of a series of 34 cases","volume":"74","author":"Rongioletti","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2023101015415131000_llad138-B6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/DAD.0000000000000988","article-title":"Interstitial granulomatous variant of scleromyxoedema \u2013 a diagnostic pitfall","volume":"40","author":"Long","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"2023101015415131000_llad138-B7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/ijd.14888","article-title":"Scleromyxedema treatment: a systematic review and update","volume":"59","author":"Haber","year":"2020","journal-title":"Int J Dermatol"},{"key":"2023101015415131000_llad138-B8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdcr.2021.10.027","article-title":"SARS-CoV-2: a potential trigger of dermato-neuro syndrome in a patient with scleromyxedema","volume":"18","author":"Fritz","year":"2021","journal-title":"JAAD Case Rep"},{"key":"2023101015415131000_llad138-B9","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.4430","article-title":"Dermato-neuro syndrome after COVID-19 vaccination in a patient with scleromyxoedema previously controlled with bortezomib and intravenous immunoglobulins","volume":"102","author":"Gallo","year":"2022","journal-title":"Acta Derm Venereol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad138\/50404638\/llad138.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/8\/945\/51990338\/llad138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/8\/945\/51990338\/llad138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:42:29Z","timestamp":1696952549000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/8\/945\/7116800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":9,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4,13]]},"published-print":{"date-parts":[[2023,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad138","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,4,13]]}}}